A larger longitudinal study across age groups (immature, mature, aged) and DMD disease severity (normal, mild, moderate, severe) using our protocol in same-sex subjects will confirm whether TSPO-PET can track multi-organ activated immune cells to better understand their contribution to dysfunctional outcomes. This evidence concerns the gene TSPO and Duchenne muscular dystrophy.